Clinical Trial Results:
A Double-blind, Proof of Concept Trial of the Use of Pegvisomant to Reduce Urinary
Albumin Excretion in Type 1 and Type 2 Diabetic Patients Treated with Angiotensin Convertase Inhibitors/Angiotensin Receptor Blockers, with Persistent Albuminuria
Summary
|
|
EudraCT number |
2004-001190-25 |
Trial protocol |
LT CZ DE GB ES DK |
Global completion date |
16 Feb 2006
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
27 Apr 2016
|
First version publication date |
07 Feb 2015
|
Other versions |
|
Summary report(s) |
A6291015 Public Disclosure Synopsis |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.